Niche Pharmacogenomics Target iGenomeDx's pharmacogenomics testing services to hospitals and clinics that seek personalized medicine solutions, emphasizing DNA-based drug matching to improve treatment efficacy and reduce adverse reactions.

SMB Recognition Leverage their minority-owned small business recognition to establish partnerships or supplier programs that prefer or incentivize collaboration with minority-owned suppliers in health care networks.

San Antonio Footprint Prioritize regional market development in San Antonio and Texas-based health systems, offering scalable lab services and rapid turnaround for infectious disease and genomic testing.

Growth Opportunity Position complementary services and managed testing programs to align with mid-market health networks, given current revenue in the low-to-mid single digits and growth potential through strategic contracts.

Competitive Gap Differentiate from larger players by emphasizing nimble, specialized pharmacogenomics testing for infectious diseases, with client education and case studies that illustrate improved outcomes and cost savings.